These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3325753)

  • 21. Bacterial and mammalian mutagenicity tests: validation and comparative studies on 180 chemicals.
    Bartsch H; Malaveille C; Camus AM; Martel-Planche G; Brun G; Hautefeuille A; Sabadie N; Barbin A; Kuroki T; Drevon C; Piccoli C; Montesano R
    IARC Sci Publ; 1980; (27):179-241. PubMed ID: 7002778
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study of the possibilities of using a short-term test system in vitro for detection of potential mutagens (carcinogens)].
    Domshlak MG; Sanotskiĭ IV; Serebrianyĭ AM
    Gig Tr Prof Zabol; 1989; (11):47-9. PubMed ID: 2515120
    [No Abstract]   [Full Text] [Related]  

  • 23. Relationships between in vitro mutagenicity assays.
    Benigni R
    Mutagenesis; 1992 Sep; 7(5):335-41. PubMed ID: 1470028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategies for the deployment of batteries of short-term tests.
    Mutat Res; 1988; 205(1-4):1-423. PubMed ID: 3367917
    [No Abstract]   [Full Text] [Related]  

  • 25. Validation study of the combined repeated-dose toxicity and genotoxicity assay using gpt delta rats.
    Akagi J; Toyoda T; Cho YM; Mizuta Y; Nohmi T; Nishikawa A; Ogawa K
    Cancer Sci; 2015 May; 106(5):529-41. PubMed ID: 25683344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The application of mutagenicity tests to the prediction of carcinogenic activity of chemicals and drugs.
    Dolara P; Caderni G
    Pharmacol Res Commun; 1984 May; 16(5):421-36. PubMed ID: 6377332
    [No Abstract]   [Full Text] [Related]  

  • 27. [Selection and application of mutagenicity tests in identification of carcinogens and mutagens. (II)].
    Wang JN
    Zhonghua Yu Fang Yi Xue Za Zhi; 1983 Sep; 17(5):313-5. PubMed ID: 6689553
    [No Abstract]   [Full Text] [Related]  

  • 28. Problems associated with the metabolic activation of carcinogens and mutagens in short-term tests.
    Bartsch H
    Dev Toxicol Environ Sci; 1980; 8():133-47. PubMed ID: 7030701
    [No Abstract]   [Full Text] [Related]  

  • 29. Updated recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests.
    Kirkland D; Kasper P; Martus HJ; Müller L; van Benthem J; Madia F; Corvi R
    Mutat Res Genet Toxicol Environ Mutagen; 2016 Jan; 795():7-30. PubMed ID: 26774663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of misleading ("false") positive results in mammalian cell genotoxicity assays. I. Choice of cell type.
    Fowler P; Smith K; Young J; Jeffrey L; Kirkland D; Pfuhler S; Carmichael P
    Mutat Res; 2012 Feb; 742(1-2):11-25. PubMed ID: 22138618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The monitoring of environmental mutagens/carcinogens. A perspective on tests predicting chemical mutagens/carcinogens in man.
    Anderson D
    Ecol Dis; 1982; 1(1):59-73. PubMed ID: 6765300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An opinion on the significance of the 19 non-clastogenic gene-mutagens reported by Tennant et al. (1987).
    Ashby J
    Mutagenesis; 1988 Nov; 3(6):463-5. PubMed ID: 3070284
    [No Abstract]   [Full Text] [Related]  

  • 33. Cooperative programme of the European Economic Community on short-term assays for mutagenicity.
    Loprieno N; Adler ID
    IARC Sci Publ; 1980; (27):331-41. PubMed ID: 7439965
    [No Abstract]   [Full Text] [Related]  

  • 34. [Recent aspects of mutagenicity tests on chemicals in our environment (author's transl)].
    Ishidate M; Yoshikawa K; Sofuni T
    Eisei Shikenjo Hokoku; 1980; 98():1-19. PubMed ID: 7018634
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparisons between in vivo and in vitro systems: the in vivo equivalent dose concept.
    Paolini M; Cantelli Forti G; Bauer C
    Mutagenesis; 1988 Nov; 3(6):527-31. PubMed ID: 3070294
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of human hepatoma cells for in vitro metabolic activation of chemical mutagens/carcinogens.
    Natarajan AT; Darroudi F
    Mutagenesis; 1991 Sep; 6(5):399-403. PubMed ID: 1665540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Short-term tests in the system of assessment of human carcinogens].
    Belitskiĭ GA; Khudoleĭ VV
    Vopr Onkol; 1986; 32(4):3-11. PubMed ID: 3518237
    [No Abstract]   [Full Text] [Related]  

  • 38. Performance of short-term tests for detection of human carcinogens.
    Kuroki T; Matsushima T
    Mutagenesis; 1987 Jan; 2(1):33-7. PubMed ID: 3331692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guidelines for the testing of chemical for mutagenicity. Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1981; 24():1-95. PubMed ID: 7244358
    [No Abstract]   [Full Text] [Related]  

  • 40. [In vivo and in vitro studies of mutagenic properties of carcinogenic N-nitramines].
    Khudoleĭ VV; Malaveille C; Bartsch H
    Vopr Onkol; 1981; 27(11):59-62. PubMed ID: 7039103
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.